Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.

The Journal of Infectious Diseases
Hunter K RoarkMark R Schleiss

Abstract

Although cytomegaloviruses (CMVs) are species-specific, the study of nonhuman CMVs in animal models can help to inform and direct research aimed at developing a human CMV (HCMV) vaccine. Because the driving force behind the development of HCMV vaccines is to prevent congenital infection, the animal model in question must be one in which vertical transmission of virus occurs to the fetus. Fortunately, two such animal models-the rhesus macaque CMV and guinea pig CMV-are characterized by congenital infection. Hence, each model can be evaluated in "proof-of-concept" studies of preconception vaccination aimed at blocking transplacental transmission. This review focuses on similarities and differences in the respective model systems, and it discusses key insights from each model germane to the study of HCMV vaccines.

References

Nov 1, 1978·The Journal of Infectious Diseases·M L Kumar, G A Nankervis
Feb 1, 1992·The Pediatric Infectious Disease Journal·S B BoppanaC A Alford
Jun 29, 1989·The New England Journal of Medicine·C A BironJ L Sullivan
Dec 1, 1989·The Journal of Infectious Diseases·N K WoolfD D Richman
Aug 1, 1985·Journal of Virology·B P GriffithE Goff
Mar 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·D M AsherR M Chanock
Mar 1, 1983·Reviews of Infectious Diseases·F J BiaG D Hsiung
Oct 1, 1995·The Journal of Infectious Diseases·D F BratcherD I Bernstein
Sep 1, 1996·Journal of Virology·C J Baldick, T Shenk
Aug 1, 1997·The Journal of General Virology·R H KravitzP A Barry
Feb 18, 1998·The Journal of Infectious Diseases·A F TarantalP A Barry
Oct 9, 1999·Journal of Virology·K M LockridgeP A Barry
Mar 8, 2000·Virology·K M LockridgeP A Barry
Feb 24, 2001·Journal of Clinical Pathology·V C Emery
Mar 13, 2001·Annual Review of Immunology·K W MooreA O'Garra
Jan 5, 2002·Journal of Virology·Juliet V SpencerThomas J Schall
Mar 22, 2002·Journal of Virology·Martina SesterHans Köhler
Oct 4, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Mark R Schleiss
Jan 21, 2003·The Journal of General Virology·Andrew J DavisonGary S Hayward
Jan 21, 2003·The Journal of General Virology·J L HuffP A Barry
Feb 25, 2003·JAMA : the Journal of the American Medical Association·Karen B FowlerRobert F Pass
Apr 12, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jennifer WuThomas Spies
May 28, 2003·Journal of Virology·Scott G HansenScott W Wong
Aug 13, 2003·The Journal of Experimental Medicine·Cristina BottinoAlessandro Moretta
Apr 24, 2004·The Journal of General Virology·Aidan DolanAndrew J Davison
Jun 3, 2004·Human Immunology·Paul Moss, Naeen Khan
Aug 12, 2004·Blood·Mónica GumáMiguel López-Botet
Aug 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Martin J RafteryGünther Schönrich

❮ Previous
Next ❯

Citations

Jul 25, 2021·International Journal of Molecular Sciences·Daniel G SausenRonen Borenstein
Aug 28, 2021·International Journal of Molecular Sciences·Evi B StrubleDorothy Scott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.